Global Artificial Dermal Matrix Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Artificial Dermal Matrix Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 122

Published Date: 13 May 2022

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Artificial Dermal Matrix market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Artificial Dermal Matrix market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Artificial Dermal Matrix global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While From Animal Source segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Artificial Dermal Matrix include MTF Biologics, Allosource, Parametrics Medical, LifeNet Health, and Gunze, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Artificial Dermal Matrix market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
From Animal Source
From Human Source

Market segment by Application, can be divided into
Hospitals
Clinics

Market segment by players, this report covers
MTF Biologics
Allosource
Parametrics Medical
LifeNet Health
Gunze
Tissue Regenix
Zimmer Biomet
Integra LifeSciences
Organogenesis
Flower Orthopedics
Promethean
Wright Medical Group
Aziyo Biologics
RTI Surgical
MiMedx Group
Tides Medical
Ventris Medical
Vivex Biomedical
Aedicell
Amniox Medical
StimLabs
Skye Biologics

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Artificial Dermal Matrix product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Artificial Dermal Matrix, with revenue, gross margin and global market share of Artificial Dermal Matrix from 2019 to 2022.
Chapter 3, the Artificial Dermal Matrix competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Artificial Dermal Matrix market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Artificial Dermal Matrix research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Artificial Dermal Matrix
1.2 Classification of Artificial Dermal Matrix by Type
1.2.1 Overview: Global Artificial Dermal Matrix Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Artificial Dermal Matrix Revenue Market Share by Type in 2021
1.2.3 From Animal Source
1.2.4 From Human Source
1.3 Global Artificial Dermal Matrix Market by Application
1.3.1 Overview: Global Artificial Dermal Matrix Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Artificial Dermal Matrix Market Size & Forecast
1.5 Global Artificial Dermal Matrix Market Size and Forecast by Region
1.5.1 Global Artificial Dermal Matrix Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Artificial Dermal Matrix Market Size by Region, (2017-2022)
1.5.3 North America Artificial Dermal Matrix Market Size and Prospect (2017-2028)
1.5.4 Europe Artificial Dermal Matrix Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Artificial Dermal Matrix Market Size and Prospect (2017-2028)
1.5.6 South America Artificial Dermal Matrix Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Artificial Dermal Matrix Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Artificial Dermal Matrix Market Drivers
1.6.2 Artificial Dermal Matrix Market Restraints
1.6.3 Artificial Dermal Matrix Trends Analysis

2 Company Profiles
2.1 MTF Biologics
2.1.1 MTF Biologics Details
2.1.2 MTF Biologics Major Business
2.1.3 MTF Biologics Artificial Dermal Matrix Product and Solutions
2.1.4 MTF Biologics Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 MTF Biologics Recent Developments and Future Plans
2.2 Allosource
2.2.1 Allosource Details
2.2.2 Allosource Major Business
2.2.3 Allosource Artificial Dermal Matrix Product and Solutions
2.2.4 Allosource Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Allosource Recent Developments and Future Plans
2.3 Parametrics Medical
2.3.1 Parametrics Medical Details
2.3.2 Parametrics Medical Major Business
2.3.3 Parametrics Medical Artificial Dermal Matrix Product and Solutions
2.3.4 Parametrics Medical Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Parametrics Medical Recent Developments and Future Plans
2.4 LifeNet Health
2.4.1 LifeNet Health Details
2.4.2 LifeNet Health Major Business
2.4.3 LifeNet Health Artificial Dermal Matrix Product and Solutions
2.4.4 LifeNet Health Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 LifeNet Health Recent Developments and Future Plans
2.5 Gunze
2.5.1 Gunze Details
2.5.2 Gunze Major Business
2.5.3 Gunze Artificial Dermal Matrix Product and Solutions
2.5.4 Gunze Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Gunze Recent Developments and Future Plans
2.6 Tissue Regenix
2.6.1 Tissue Regenix Details
2.6.2 Tissue Regenix Major Business
2.6.3 Tissue Regenix Artificial Dermal Matrix Product and Solutions
2.6.4 Tissue Regenix Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Tissue Regenix Recent Developments and Future Plans
2.7 Zimmer Biomet
2.7.1 Zimmer Biomet Details
2.7.2 Zimmer Biomet Major Business
2.7.3 Zimmer Biomet Artificial Dermal Matrix Product and Solutions
2.7.4 Zimmer Biomet Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Zimmer Biomet Recent Developments and Future Plans
2.8 Integra LifeSciences
2.8.1 Integra LifeSciences Details
2.8.2 Integra LifeSciences Major Business
2.8.3 Integra LifeSciences Artificial Dermal Matrix Product and Solutions
2.8.4 Integra LifeSciences Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Integra LifeSciences Recent Developments and Future Plans
2.9 Organogenesis
2.9.1 Organogenesis Details
2.9.2 Organogenesis Major Business
2.9.3 Organogenesis Artificial Dermal Matrix Product and Solutions
2.9.4 Organogenesis Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Organogenesis Recent Developments and Future Plans
2.10 Flower Orthopedics
2.10.1 Flower Orthopedics Details
2.10.2 Flower Orthopedics Major Business
2.10.3 Flower Orthopedics Artificial Dermal Matrix Product and Solutions
2.10.4 Flower Orthopedics Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Flower Orthopedics Recent Developments and Future Plans
2.11 Promethean
2.11.1 Promethean Details
2.11.2 Promethean Major Business
2.11.3 Promethean Artificial Dermal Matrix Product and Solutions
2.11.4 Promethean Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Promethean Recent Developments and Future Plans
2.12 Wright Medical Group
2.12.1 Wright Medical Group Details
2.12.2 Wright Medical Group Major Business
2.12.3 Wright Medical Group Artificial Dermal Matrix Product and Solutions
2.12.4 Wright Medical Group Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Wright Medical Group Recent Developments and Future Plans
2.13 Aziyo Biologics
2.13.1 Aziyo Biologics Details
2.13.2 Aziyo Biologics Major Business
2.13.3 Aziyo Biologics Artificial Dermal Matrix Product and Solutions
2.13.4 Aziyo Biologics Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Aziyo Biologics Recent Developments and Future Plans
2.14 RTI Surgical
2.14.1 RTI Surgical Details
2.14.2 RTI Surgical Major Business
2.14.3 RTI Surgical Artificial Dermal Matrix Product and Solutions
2.14.4 RTI Surgical Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 RTI Surgical Recent Developments and Future Plans
2.15 MiMedx Group
2.15.1 MiMedx Group Details
2.15.2 MiMedx Group Major Business
2.15.3 MiMedx Group Artificial Dermal Matrix Product and Solutions
2.15.4 MiMedx Group Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 MiMedx Group Recent Developments and Future Plans
2.16 Tides Medical
2.16.1 Tides Medical Details
2.16.2 Tides Medical Major Business
2.16.3 Tides Medical Artificial Dermal Matrix Product and Solutions
2.16.4 Tides Medical Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Tides Medical Recent Developments and Future Plans
2.17 Ventris Medical
2.17.1 Ventris Medical Details
2.17.2 Ventris Medical Major Business
2.17.3 Ventris Medical Artificial Dermal Matrix Product and Solutions
2.17.4 Ventris Medical Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Ventris Medical Recent Developments and Future Plans
2.18 Vivex Biomedical
2.18.1 Vivex Biomedical Details
2.18.2 Vivex Biomedical Major Business
2.18.3 Vivex Biomedical Artificial Dermal Matrix Product and Solutions
2.18.4 Vivex Biomedical Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Vivex Biomedical Recent Developments and Future Plans
2.19 Aedicell
2.19.1 Aedicell Details
2.19.2 Aedicell Major Business
2.19.3 Aedicell Artificial Dermal Matrix Product and Solutions
2.19.4 Aedicell Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Aedicell Recent Developments and Future Plans
2.20 Amniox Medical
2.20.1 Amniox Medical Details
2.20.2 Amniox Medical Major Business
2.20.3 Amniox Medical Artificial Dermal Matrix Product and Solutions
2.20.4 Amniox Medical Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 Amniox Medical Recent Developments and Future Plans
2.21 StimLabs
2.21.1 StimLabs Details
2.21.2 StimLabs Major Business
2.21.3 StimLabs Artificial Dermal Matrix Product and Solutions
2.21.4 StimLabs Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 StimLabs Recent Developments and Future Plans
2.22 Skye Biologics
2.22.1 Skye Biologics Details
2.22.2 Skye Biologics Major Business
2.22.3 Skye Biologics Artificial Dermal Matrix Product and Solutions
2.22.4 Skye Biologics Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22.5 Skye Biologics Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Artificial Dermal Matrix Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Artificial Dermal Matrix Players Market Share in 2021
3.2.2 Top 10 Artificial Dermal Matrix Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Artificial Dermal Matrix Players Head Office, Products and Services Provided
3.4 Artificial Dermal Matrix Mergers & Acquisitions
3.5 Artificial Dermal Matrix New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Artificial Dermal Matrix Revenue and Market Share by Type (2017-2022)
4.2 Global Artificial Dermal Matrix Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
5.1 Global Artificial Dermal Matrix Revenue Market Share by Application (2017-2022)
5.2 Global Artificial Dermal Matrix Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
6.1 North America Artificial Dermal Matrix Revenue by Type (2017-2028)
6.2 North America Artificial Dermal Matrix Revenue by Application (2017-2028)
6.3 North America Artificial Dermal Matrix Market Size by Country
6.3.1 North America Artificial Dermal Matrix Revenue by Country (2017-2028)
6.3.2 United States Artificial Dermal Matrix Market Size and Forecast (2017-2028)
6.3.3 Canada Artificial Dermal Matrix Market Size and Forecast (2017-2028)
6.3.4 Mexico Artificial Dermal Matrix Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
7.1 Europe Artificial Dermal Matrix Revenue by Type (2017-2028)
7.2 Europe Artificial Dermal Matrix Revenue by Application (2017-2028)
7.3 Europe Artificial Dermal Matrix Market Size by Country
7.3.1 Europe Artificial Dermal Matrix Revenue by Country (2017-2028)
7.3.2 Germany Artificial Dermal Matrix Market Size and Forecast (2017-2028)
7.3.3 France Artificial Dermal Matrix Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Artificial Dermal Matrix Market Size and Forecast (2017-2028)
7.3.5 Russia Artificial Dermal Matrix Market Size and Forecast (2017-2028)
7.3.6 Italy Artificial Dermal Matrix Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Artificial Dermal Matrix Revenue by Type (2017-2028)
8.2 Asia-Pacific Artificial Dermal Matrix Revenue by Application (2017-2028)
8.3 Asia-Pacific Artificial Dermal Matrix Market Size by Region
8.3.1 Asia-Pacific Artificial Dermal Matrix Revenue by Region (2017-2028)
8.3.2 China Artificial Dermal Matrix Market Size and Forecast (2017-2028)
8.3.3 Japan Artificial Dermal Matrix Market Size and Forecast (2017-2028)
8.3.4 South Korea Artificial Dermal Matrix Market Size and Forecast (2017-2028)
8.3.5 India Artificial Dermal Matrix Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Artificial Dermal Matrix Market Size and Forecast (2017-2028)
8.3.7 Australia Artificial Dermal Matrix Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
9.1 South America Artificial Dermal Matrix Revenue by Type (2017-2028)
9.2 South America Artificial Dermal Matrix Revenue by Application (2017-2028)
9.3 South America Artificial Dermal Matrix Market Size by Country
9.3.1 South America Artificial Dermal Matrix Revenue by Country (2017-2028)
9.3.2 Brazil Artificial Dermal Matrix Market Size and Forecast (2017-2028)
9.3.3 Argentina Artificial Dermal Matrix Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Artificial Dermal Matrix Revenue by Type (2017-2028)
10.2 Middle East & Africa Artificial Dermal Matrix Revenue by Application (2017-2028)
10.3 Middle East & Africa Artificial Dermal Matrix Market Size by Country
10.3.1 Middle East & Africa Artificial Dermal Matrix Revenue by Country (2017-2028)
10.3.2 Turkey Artificial Dermal Matrix Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Artificial Dermal Matrix Market Size and Forecast (2017-2028)
10.3.4 UAE Artificial Dermal Matrix Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Artificial Dermal Matrix Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Artificial Dermal Matrix Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Artificial Dermal Matrix Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Artificial Dermal Matrix Revenue (USD Million) by Region (2017-2022)
Table 5. Global Artificial Dermal Matrix Revenue Market Share by Region (2023-2028)
Table 6. MTF Biologics Corporate Information, Head Office, and Major Competitors
Table 7. MTF Biologics Major Business
Table 8. MTF Biologics Artificial Dermal Matrix Product and Solutions
Table 9. MTF Biologics Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Allosource Corporate Information, Head Office, and Major Competitors
Table 11. Allosource Major Business
Table 12. Allosource Artificial Dermal Matrix Product and Solutions
Table 13. Allosource Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Parametrics Medical Corporate Information, Head Office, and Major Competitors
Table 15. Parametrics Medical Major Business
Table 16. Parametrics Medical Artificial Dermal Matrix Product and Solutions
Table 17. Parametrics Medical Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. LifeNet Health Corporate Information, Head Office, and Major Competitors
Table 19. LifeNet Health Major Business
Table 20. LifeNet Health Artificial Dermal Matrix Product and Solutions
Table 21. LifeNet Health Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Gunze Corporate Information, Head Office, and Major Competitors
Table 23. Gunze Major Business
Table 24. Gunze Artificial Dermal Matrix Product and Solutions
Table 25. Gunze Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Tissue Regenix Corporate Information, Head Office, and Major Competitors
Table 27. Tissue Regenix Major Business
Table 28. Tissue Regenix Artificial Dermal Matrix Product and Solutions
Table 29. Tissue Regenix Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Zimmer Biomet Corporate Information, Head Office, and Major Competitors
Table 31. Zimmer Biomet Major Business
Table 32. Zimmer Biomet Artificial Dermal Matrix Product and Solutions
Table 33. Zimmer Biomet Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Integra LifeSciences Corporate Information, Head Office, and Major Competitors
Table 35. Integra LifeSciences Major Business
Table 36. Integra LifeSciences Artificial Dermal Matrix Product and Solutions
Table 37. Integra LifeSciences Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Organogenesis Corporate Information, Head Office, and Major Competitors
Table 39. Organogenesis Major Business
Table 40. Organogenesis Artificial Dermal Matrix Product and Solutions
Table 41. Organogenesis Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Flower Orthopedics Corporate Information, Head Office, and Major Competitors
Table 43. Flower Orthopedics Major Business
Table 44. Flower Orthopedics Artificial Dermal Matrix Product and Solutions
Table 45. Flower Orthopedics Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Promethean Corporate Information, Head Office, and Major Competitors
Table 47. Promethean Major Business
Table 48. Promethean Artificial Dermal Matrix Product and Solutions
Table 49. Promethean Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Wright Medical Group Corporate Information, Head Office, and Major Competitors
Table 51. Wright Medical Group Major Business
Table 52. Wright Medical Group Artificial Dermal Matrix Product and Solutions
Table 53. Wright Medical Group Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Aziyo Biologics Corporate Information, Head Office, and Major Competitors
Table 55. Aziyo Biologics Major Business
Table 56. Aziyo Biologics Artificial Dermal Matrix Product and Solutions
Table 57. Aziyo Biologics Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. RTI Surgical Corporate Information, Head Office, and Major Competitors
Table 59. RTI Surgical Major Business
Table 60. RTI Surgical Artificial Dermal Matrix Product and Solutions
Table 61. RTI Surgical Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. MiMedx Group Corporate Information, Head Office, and Major Competitors
Table 63. MiMedx Group Major Business
Table 64. MiMedx Group Artificial Dermal Matrix Product and Solutions
Table 65. MiMedx Group Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Tides Medical Corporate Information, Head Office, and Major Competitors
Table 67. Tides Medical Major Business
Table 68. Tides Medical Artificial Dermal Matrix Product and Solutions
Table 69. Tides Medical Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Ventris Medical Corporate Information, Head Office, and Major Competitors
Table 71. Ventris Medical Major Business
Table 72. Ventris Medical Artificial Dermal Matrix Product and Solutions
Table 73. Ventris Medical Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Vivex Biomedical Corporate Information, Head Office, and Major Competitors
Table 75. Vivex Biomedical Major Business
Table 76. Vivex Biomedical Artificial Dermal Matrix Product and Solutions
Table 77. Vivex Biomedical Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Aedicell Corporate Information, Head Office, and Major Competitors
Table 79. Aedicell Major Business
Table 80. Aedicell Artificial Dermal Matrix Product and Solutions
Table 81. Aedicell Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Amniox Medical Corporate Information, Head Office, and Major Competitors
Table 83. Amniox Medical Major Business
Table 84. Amniox Medical Artificial Dermal Matrix Product and Solutions
Table 85. Amniox Medical Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. StimLabs Corporate Information, Head Office, and Major Competitors
Table 87. StimLabs Major Business
Table 88. StimLabs Artificial Dermal Matrix Product and Solutions
Table 89. StimLabs Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Skye Biologics Corporate Information, Head Office, and Major Competitors
Table 91. Skye Biologics Major Business
Table 92. Skye Biologics Artificial Dermal Matrix Product and Solutions
Table 93. Skye Biologics Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 94. Global Artificial Dermal Matrix Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 95. Global Artificial Dermal Matrix Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 96. Breakdown of Artificial Dermal Matrix by Company Type (Tier 1, Tier 2 and Tier 3)
Table 97. Artificial Dermal Matrix Players Head Office, Products and Services Provided
Table 98. Artificial Dermal Matrix Mergers & Acquisitions in the Past Five Years
Table 99. Artificial Dermal Matrix New Entrants and Expansion Plans
Table 100. Global Artificial Dermal Matrix Revenue (USD Million) by Type (2017-2022)
Table 101. Global Artificial Dermal Matrix Revenue Share by Type (2017-2022)
Table 102. Global Artificial Dermal Matrix Revenue Forecast by Type (2023-2028)
Table 103. Global Artificial Dermal Matrix Revenue by Application (2017-2022)
Table 104. Global Artificial Dermal Matrix Revenue Forecast by Application (2023-2028)
Table 105. North America Artificial Dermal Matrix Revenue by Type (2017-2022) & (USD Million)
Table 106. North America Artificial Dermal Matrix Revenue by Type (2023-2028) & (USD Million)
Table 107. North America Artificial Dermal Matrix Revenue by Application (2017-2022) & (USD Million)
Table 108. North America Artificial Dermal Matrix Revenue by Application (2023-2028) & (USD Million)
Table 109. North America Artificial Dermal Matrix Revenue by Country (2017-2022) & (USD Million)
Table 110. North America Artificial Dermal Matrix Revenue by Country (2023-2028) & (USD Million)
Table 111. Europe Artificial Dermal Matrix Revenue by Type (2017-2022) & (USD Million)
Table 112. Europe Artificial Dermal Matrix Revenue by Type (2023-2028) & (USD Million)
Table 113. Europe Artificial Dermal Matrix Revenue by Application (2017-2022) & (USD Million)
Table 114. Europe Artificial Dermal Matrix Revenue by Application (2023-2028) & (USD Million)
Table 115. Europe Artificial Dermal Matrix Revenue by Country (2017-2022) & (USD Million)
Table 116. Europe Artificial Dermal Matrix Revenue by Country (2023-2028) & (USD Million)
Table 117. Asia-Pacific Artificial Dermal Matrix Revenue by Type (2017-2022) & (USD Million)
Table 118. Asia-Pacific Artificial Dermal Matrix Revenue by Type (2023-2028) & (USD Million)
Table 119. Asia-Pacific Artificial Dermal Matrix Revenue by Application (2017-2022) & (USD Million)
Table 120. Asia-Pacific Artificial Dermal Matrix Revenue by Application (2023-2028) & (USD Million)
Table 121. Asia-Pacific Artificial Dermal Matrix Revenue by Region (2017-2022) & (USD Million)
Table 122. Asia-Pacific Artificial Dermal Matrix Revenue by Region (2023-2028) & (USD Million)
Table 123. South America Artificial Dermal Matrix Revenue by Type (2017-2022) & (USD Million)
Table 124. South America Artificial Dermal Matrix Revenue by Type (2023-2028) & (USD Million)
Table 125. South America Artificial Dermal Matrix Revenue by Application (2017-2022) & (USD Million)
Table 126. South America Artificial Dermal Matrix Revenue by Application (2023-2028) & (USD Million)
Table 127. South America Artificial Dermal Matrix Revenue by Country (2017-2022) & (USD Million)
Table 128. South America Artificial Dermal Matrix Revenue by Country (2023-2028) & (USD Million)
Table 129. Middle East & Africa Artificial Dermal Matrix Revenue by Type (2017-2022) & (USD Million)
Table 130. Middle East & Africa Artificial Dermal Matrix Revenue by Type (2023-2028) & (USD Million)
Table 131. Middle East & Africa Artificial Dermal Matrix Revenue by Application (2017-2022) & (USD Million)
Table 132. Middle East & Africa Artificial Dermal Matrix Revenue by Application (2023-2028) & (USD Million)
Table 133. Middle East & Africa Artificial Dermal Matrix Revenue by Country (2017-2022) & (USD Million)
Table 134. Middle East & Africa Artificial Dermal Matrix Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Artificial Dermal Matrix Picture
Figure 2. Global Artificial Dermal Matrix Revenue Market Share by Type in 2021
Figure 3. From Animal Source
Figure 4. From Human Source
Figure 5. Artificial Dermal Matrix Revenue Market Share by Application in 2021
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Global Artificial Dermal Matrix Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 9. Global Artificial Dermal Matrix Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Artificial Dermal Matrix Revenue Market Share by Region (2017-2028)
Figure 11. Global Artificial Dermal Matrix Revenue Market Share by Region in 2021
Figure 12. North America Artificial Dermal Matrix Revenue (USD Million) and Growth Rate (2017-2028)
Figure 13. Europe Artificial Dermal Matrix Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Asia-Pacific Artificial Dermal Matrix Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. South America Artificial Dermal Matrix Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Middle East and Africa Artificial Dermal Matrix Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Artificial Dermal Matrix Market Drivers
Figure 18. Artificial Dermal Matrix Market Restraints
Figure 19. Artificial Dermal Matrix Market Trends
Figure 20. MTF Biologics Recent Developments and Future Plans
Figure 21. Allosource Recent Developments and Future Plans
Figure 22. Parametrics Medical Recent Developments and Future Plans
Figure 23. LifeNet Health Recent Developments and Future Plans
Figure 24. Gunze Recent Developments and Future Plans
Figure 25. Tissue Regenix Recent Developments and Future Plans
Figure 26. Zimmer Biomet Recent Developments and Future Plans
Figure 27. Integra LifeSciences Recent Developments and Future Plans
Figure 28. Organogenesis Recent Developments and Future Plans
Figure 29. Flower Orthopedics Recent Developments and Future Plans
Figure 30. Promethean Recent Developments and Future Plans
Figure 31. Wright Medical Group Recent Developments and Future Plans
Figure 32. Aziyo Biologics Recent Developments and Future Plans
Figure 33. RTI Surgical Recent Developments and Future Plans
Figure 34. MiMedx Group Recent Developments and Future Plans
Figure 35. Tides Medical Recent Developments and Future Plans
Figure 36. Ventris Medical Recent Developments and Future Plans
Figure 37. Vivex Biomedical Recent Developments and Future Plans
Figure 38. Aedicell Recent Developments and Future Plans
Figure 39. Amniox Medical Recent Developments and Future Plans
Figure 40. StimLabs Recent Developments and Future Plans
Figure 41. Skye Biologics Recent Developments and Future Plans
Figure 42. Global Artificial Dermal Matrix Revenue Share by Players in 2021
Figure 43. Artificial Dermal Matrix Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 44. Global Top 3 Players Artificial Dermal Matrix Revenue Market Share in 2021
Figure 45. Global Top 10 Players Artificial Dermal Matrix Revenue Market Share in 2021
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 47. Global Artificial Dermal Matrix Revenue Share by Type in 2021
Figure 48. Global Artificial Dermal Matrix Market Share Forecast by Type (2023-2028)
Figure 49. Global Artificial Dermal Matrix Revenue Share by Application in 2021
Figure 50. Global Artificial Dermal Matrix Market Share Forecast by Application (2023-2028)
Figure 51. North America Artificial Dermal Matrix Sales Market Share by Type (2017-2028)
Figure 52. North America Artificial Dermal Matrix Sales Market Share by Application (2017-2028)
Figure 53. North America Artificial Dermal Matrix Revenue Market Share by Country (2017-2028)
Figure 54. United States Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Canada Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Mexico Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Europe Artificial Dermal Matrix Sales Market Share by Type (2017-2028)
Figure 58. Europe Artificial Dermal Matrix Sales Market Share by Application (2017-2028)
Figure 59. Europe Artificial Dermal Matrix Revenue Market Share by Country (2017-2028)
Figure 60. Germany Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. France Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. United Kingdom Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Russia Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Italy Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Asia-Pacific Artificial Dermal Matrix Sales Market Share by Type (2017-2028)
Figure 66. Asia-Pacific Artificial Dermal Matrix Sales Market Share by Application (2017-2028)
Figure 67. Asia-Pacific Artificial Dermal Matrix Revenue Market Share by Region (2017-2028)
Figure 68. China Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Japan Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South Korea Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. India Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Southeast Asia Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Australia Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South America Artificial Dermal Matrix Sales Market Share by Type (2017-2028)
Figure 75. South America Artificial Dermal Matrix Sales Market Share by Application (2017-2028)
Figure 76. South America Artificial Dermal Matrix Revenue Market Share by Country (2017-2028)
Figure 77. Brazil Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Argentina Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Middle East and Africa Artificial Dermal Matrix Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Artificial Dermal Matrix Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Artificial Dermal Matrix Revenue Market Share by Country (2017-2028)
Figure 82. Turkey Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Saudi Arabia Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. UAE Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

MTF Biologics
Allosource
Parametrics Medical
LifeNet Health
Gunze
Tissue Regenix
Zimmer Biomet
Integra LifeSciences
Organogenesis
Flower Orthopedics
Promethean
Wright Medical Group
Aziyo Biologics
RTI Surgical
MiMedx Group
Tides Medical
Ventris Medical
Vivex Biomedical
Aedicell
Amniox Medical
StimLabs
Skye Biologics
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Artificial Dermal Matrix Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Artificial Dermal Matrix Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 122

Published Date: 13 May 2022

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Artificial Dermal Matrix market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Artificial Dermal Matrix market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Artificial Dermal Matrix global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While From Animal Source segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Artificial Dermal Matrix include MTF Biologics, Allosource, Parametrics Medical, LifeNet Health, and Gunze, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Artificial Dermal Matrix market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
From Animal Source
From Human Source

Market segment by Application, can be divided into
Hospitals
Clinics

Market segment by players, this report covers
MTF Biologics
Allosource
Parametrics Medical
LifeNet Health
Gunze
Tissue Regenix
Zimmer Biomet
Integra LifeSciences
Organogenesis
Flower Orthopedics
Promethean
Wright Medical Group
Aziyo Biologics
RTI Surgical
MiMedx Group
Tides Medical
Ventris Medical
Vivex Biomedical
Aedicell
Amniox Medical
StimLabs
Skye Biologics

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Artificial Dermal Matrix product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Artificial Dermal Matrix, with revenue, gross margin and global market share of Artificial Dermal Matrix from 2019 to 2022.
Chapter 3, the Artificial Dermal Matrix competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Artificial Dermal Matrix market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Artificial Dermal Matrix research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Artificial Dermal Matrix
1.2 Classification of Artificial Dermal Matrix by Type
1.2.1 Overview: Global Artificial Dermal Matrix Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Artificial Dermal Matrix Revenue Market Share by Type in 2021
1.2.3 From Animal Source
1.2.4 From Human Source
1.3 Global Artificial Dermal Matrix Market by Application
1.3.1 Overview: Global Artificial Dermal Matrix Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Artificial Dermal Matrix Market Size & Forecast
1.5 Global Artificial Dermal Matrix Market Size and Forecast by Region
1.5.1 Global Artificial Dermal Matrix Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Artificial Dermal Matrix Market Size by Region, (2017-2022)
1.5.3 North America Artificial Dermal Matrix Market Size and Prospect (2017-2028)
1.5.4 Europe Artificial Dermal Matrix Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Artificial Dermal Matrix Market Size and Prospect (2017-2028)
1.5.6 South America Artificial Dermal Matrix Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Artificial Dermal Matrix Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Artificial Dermal Matrix Market Drivers
1.6.2 Artificial Dermal Matrix Market Restraints
1.6.3 Artificial Dermal Matrix Trends Analysis

2 Company Profiles
2.1 MTF Biologics
2.1.1 MTF Biologics Details
2.1.2 MTF Biologics Major Business
2.1.3 MTF Biologics Artificial Dermal Matrix Product and Solutions
2.1.4 MTF Biologics Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 MTF Biologics Recent Developments and Future Plans
2.2 Allosource
2.2.1 Allosource Details
2.2.2 Allosource Major Business
2.2.3 Allosource Artificial Dermal Matrix Product and Solutions
2.2.4 Allosource Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Allosource Recent Developments and Future Plans
2.3 Parametrics Medical
2.3.1 Parametrics Medical Details
2.3.2 Parametrics Medical Major Business
2.3.3 Parametrics Medical Artificial Dermal Matrix Product and Solutions
2.3.4 Parametrics Medical Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Parametrics Medical Recent Developments and Future Plans
2.4 LifeNet Health
2.4.1 LifeNet Health Details
2.4.2 LifeNet Health Major Business
2.4.3 LifeNet Health Artificial Dermal Matrix Product and Solutions
2.4.4 LifeNet Health Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 LifeNet Health Recent Developments and Future Plans
2.5 Gunze
2.5.1 Gunze Details
2.5.2 Gunze Major Business
2.5.3 Gunze Artificial Dermal Matrix Product and Solutions
2.5.4 Gunze Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Gunze Recent Developments and Future Plans
2.6 Tissue Regenix
2.6.1 Tissue Regenix Details
2.6.2 Tissue Regenix Major Business
2.6.3 Tissue Regenix Artificial Dermal Matrix Product and Solutions
2.6.4 Tissue Regenix Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Tissue Regenix Recent Developments and Future Plans
2.7 Zimmer Biomet
2.7.1 Zimmer Biomet Details
2.7.2 Zimmer Biomet Major Business
2.7.3 Zimmer Biomet Artificial Dermal Matrix Product and Solutions
2.7.4 Zimmer Biomet Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Zimmer Biomet Recent Developments and Future Plans
2.8 Integra LifeSciences
2.8.1 Integra LifeSciences Details
2.8.2 Integra LifeSciences Major Business
2.8.3 Integra LifeSciences Artificial Dermal Matrix Product and Solutions
2.8.4 Integra LifeSciences Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Integra LifeSciences Recent Developments and Future Plans
2.9 Organogenesis
2.9.1 Organogenesis Details
2.9.2 Organogenesis Major Business
2.9.3 Organogenesis Artificial Dermal Matrix Product and Solutions
2.9.4 Organogenesis Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Organogenesis Recent Developments and Future Plans
2.10 Flower Orthopedics
2.10.1 Flower Orthopedics Details
2.10.2 Flower Orthopedics Major Business
2.10.3 Flower Orthopedics Artificial Dermal Matrix Product and Solutions
2.10.4 Flower Orthopedics Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Flower Orthopedics Recent Developments and Future Plans
2.11 Promethean
2.11.1 Promethean Details
2.11.2 Promethean Major Business
2.11.3 Promethean Artificial Dermal Matrix Product and Solutions
2.11.4 Promethean Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Promethean Recent Developments and Future Plans
2.12 Wright Medical Group
2.12.1 Wright Medical Group Details
2.12.2 Wright Medical Group Major Business
2.12.3 Wright Medical Group Artificial Dermal Matrix Product and Solutions
2.12.4 Wright Medical Group Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Wright Medical Group Recent Developments and Future Plans
2.13 Aziyo Biologics
2.13.1 Aziyo Biologics Details
2.13.2 Aziyo Biologics Major Business
2.13.3 Aziyo Biologics Artificial Dermal Matrix Product and Solutions
2.13.4 Aziyo Biologics Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Aziyo Biologics Recent Developments and Future Plans
2.14 RTI Surgical
2.14.1 RTI Surgical Details
2.14.2 RTI Surgical Major Business
2.14.3 RTI Surgical Artificial Dermal Matrix Product and Solutions
2.14.4 RTI Surgical Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 RTI Surgical Recent Developments and Future Plans
2.15 MiMedx Group
2.15.1 MiMedx Group Details
2.15.2 MiMedx Group Major Business
2.15.3 MiMedx Group Artificial Dermal Matrix Product and Solutions
2.15.4 MiMedx Group Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 MiMedx Group Recent Developments and Future Plans
2.16 Tides Medical
2.16.1 Tides Medical Details
2.16.2 Tides Medical Major Business
2.16.3 Tides Medical Artificial Dermal Matrix Product and Solutions
2.16.4 Tides Medical Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Tides Medical Recent Developments and Future Plans
2.17 Ventris Medical
2.17.1 Ventris Medical Details
2.17.2 Ventris Medical Major Business
2.17.3 Ventris Medical Artificial Dermal Matrix Product and Solutions
2.17.4 Ventris Medical Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Ventris Medical Recent Developments and Future Plans
2.18 Vivex Biomedical
2.18.1 Vivex Biomedical Details
2.18.2 Vivex Biomedical Major Business
2.18.3 Vivex Biomedical Artificial Dermal Matrix Product and Solutions
2.18.4 Vivex Biomedical Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Vivex Biomedical Recent Developments and Future Plans
2.19 Aedicell
2.19.1 Aedicell Details
2.19.2 Aedicell Major Business
2.19.3 Aedicell Artificial Dermal Matrix Product and Solutions
2.19.4 Aedicell Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Aedicell Recent Developments and Future Plans
2.20 Amniox Medical
2.20.1 Amniox Medical Details
2.20.2 Amniox Medical Major Business
2.20.3 Amniox Medical Artificial Dermal Matrix Product and Solutions
2.20.4 Amniox Medical Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 Amniox Medical Recent Developments and Future Plans
2.21 StimLabs
2.21.1 StimLabs Details
2.21.2 StimLabs Major Business
2.21.3 StimLabs Artificial Dermal Matrix Product and Solutions
2.21.4 StimLabs Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 StimLabs Recent Developments and Future Plans
2.22 Skye Biologics
2.22.1 Skye Biologics Details
2.22.2 Skye Biologics Major Business
2.22.3 Skye Biologics Artificial Dermal Matrix Product and Solutions
2.22.4 Skye Biologics Artificial Dermal Matrix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22.5 Skye Biologics Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Artificial Dermal Matrix Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Artificial Dermal Matrix Players Market Share in 2021
3.2.2 Top 10 Artificial Dermal Matrix Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Artificial Dermal Matrix Players Head Office, Products and Services Provided
3.4 Artificial Dermal Matrix Mergers & Acquisitions
3.5 Artificial Dermal Matrix New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Artificial Dermal Matrix Revenue and Market Share by Type (2017-2022)
4.2 Global Artificial Dermal Matrix Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
5.1 Global Artificial Dermal Matrix Revenue Market Share by Application (2017-2022)
5.2 Global Artificial Dermal Matrix Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
6.1 North America Artificial Dermal Matrix Revenue by Type (2017-2028)
6.2 North America Artificial Dermal Matrix Revenue by Application (2017-2028)
6.3 North America Artificial Dermal Matrix Market Size by Country
6.3.1 North America Artificial Dermal Matrix Revenue by Country (2017-2028)
6.3.2 United States Artificial Dermal Matrix Market Size and Forecast (2017-2028)
6.3.3 Canada Artificial Dermal Matrix Market Size and Forecast (2017-2028)
6.3.4 Mexico Artificial Dermal Matrix Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
7.1 Europe Artificial Dermal Matrix Revenue by Type (2017-2028)
7.2 Europe Artificial Dermal Matrix Revenue by Application (2017-2028)
7.3 Europe Artificial Dermal Matrix Market Size by Country
7.3.1 Europe Artificial Dermal Matrix Revenue by Country (2017-2028)
7.3.2 Germany Artificial Dermal Matrix Market Size and Forecast (2017-2028)
7.3.3 France Artificial Dermal Matrix Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Artificial Dermal Matrix Market Size and Forecast (2017-2028)
7.3.5 Russia Artificial Dermal Matrix Market Size and Forecast (2017-2028)
7.3.6 Italy Artificial Dermal Matrix Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Artificial Dermal Matrix Revenue by Type (2017-2028)
8.2 Asia-Pacific Artificial Dermal Matrix Revenue by Application (2017-2028)
8.3 Asia-Pacific Artificial Dermal Matrix Market Size by Region
8.3.1 Asia-Pacific Artificial Dermal Matrix Revenue by Region (2017-2028)
8.3.2 China Artificial Dermal Matrix Market Size and Forecast (2017-2028)
8.3.3 Japan Artificial Dermal Matrix Market Size and Forecast (2017-2028)
8.3.4 South Korea Artificial Dermal Matrix Market Size and Forecast (2017-2028)
8.3.5 India Artificial Dermal Matrix Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Artificial Dermal Matrix Market Size and Forecast (2017-2028)
8.3.7 Australia Artificial Dermal Matrix Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
9.1 South America Artificial Dermal Matrix Revenue by Type (2017-2028)
9.2 South America Artificial Dermal Matrix Revenue by Application (2017-2028)
9.3 South America Artificial Dermal Matrix Market Size by Country
9.3.1 South America Artificial Dermal Matrix Revenue by Country (2017-2028)
9.3.2 Brazil Artificial Dermal Matrix Market Size and Forecast (2017-2028)
9.3.3 Argentina Artificial Dermal Matrix Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Artificial Dermal Matrix Revenue by Type (2017-2028)
10.2 Middle East & Africa Artificial Dermal Matrix Revenue by Application (2017-2028)
10.3 Middle East & Africa Artificial Dermal Matrix Market Size by Country
10.3.1 Middle East & Africa Artificial Dermal Matrix Revenue by Country (2017-2028)
10.3.2 Turkey Artificial Dermal Matrix Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Artificial Dermal Matrix Market Size and Forecast (2017-2028)
10.3.4 UAE Artificial Dermal Matrix Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Artificial Dermal Matrix Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Artificial Dermal Matrix Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Artificial Dermal Matrix Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Artificial Dermal Matrix Revenue (USD Million) by Region (2017-2022)
Table 5. Global Artificial Dermal Matrix Revenue Market Share by Region (2023-2028)
Table 6. MTF Biologics Corporate Information, Head Office, and Major Competitors
Table 7. MTF Biologics Major Business
Table 8. MTF Biologics Artificial Dermal Matrix Product and Solutions
Table 9. MTF Biologics Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Allosource Corporate Information, Head Office, and Major Competitors
Table 11. Allosource Major Business
Table 12. Allosource Artificial Dermal Matrix Product and Solutions
Table 13. Allosource Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Parametrics Medical Corporate Information, Head Office, and Major Competitors
Table 15. Parametrics Medical Major Business
Table 16. Parametrics Medical Artificial Dermal Matrix Product and Solutions
Table 17. Parametrics Medical Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. LifeNet Health Corporate Information, Head Office, and Major Competitors
Table 19. LifeNet Health Major Business
Table 20. LifeNet Health Artificial Dermal Matrix Product and Solutions
Table 21. LifeNet Health Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Gunze Corporate Information, Head Office, and Major Competitors
Table 23. Gunze Major Business
Table 24. Gunze Artificial Dermal Matrix Product and Solutions
Table 25. Gunze Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Tissue Regenix Corporate Information, Head Office, and Major Competitors
Table 27. Tissue Regenix Major Business
Table 28. Tissue Regenix Artificial Dermal Matrix Product and Solutions
Table 29. Tissue Regenix Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Zimmer Biomet Corporate Information, Head Office, and Major Competitors
Table 31. Zimmer Biomet Major Business
Table 32. Zimmer Biomet Artificial Dermal Matrix Product and Solutions
Table 33. Zimmer Biomet Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Integra LifeSciences Corporate Information, Head Office, and Major Competitors
Table 35. Integra LifeSciences Major Business
Table 36. Integra LifeSciences Artificial Dermal Matrix Product and Solutions
Table 37. Integra LifeSciences Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Organogenesis Corporate Information, Head Office, and Major Competitors
Table 39. Organogenesis Major Business
Table 40. Organogenesis Artificial Dermal Matrix Product and Solutions
Table 41. Organogenesis Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Flower Orthopedics Corporate Information, Head Office, and Major Competitors
Table 43. Flower Orthopedics Major Business
Table 44. Flower Orthopedics Artificial Dermal Matrix Product and Solutions
Table 45. Flower Orthopedics Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Promethean Corporate Information, Head Office, and Major Competitors
Table 47. Promethean Major Business
Table 48. Promethean Artificial Dermal Matrix Product and Solutions
Table 49. Promethean Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Wright Medical Group Corporate Information, Head Office, and Major Competitors
Table 51. Wright Medical Group Major Business
Table 52. Wright Medical Group Artificial Dermal Matrix Product and Solutions
Table 53. Wright Medical Group Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Aziyo Biologics Corporate Information, Head Office, and Major Competitors
Table 55. Aziyo Biologics Major Business
Table 56. Aziyo Biologics Artificial Dermal Matrix Product and Solutions
Table 57. Aziyo Biologics Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. RTI Surgical Corporate Information, Head Office, and Major Competitors
Table 59. RTI Surgical Major Business
Table 60. RTI Surgical Artificial Dermal Matrix Product and Solutions
Table 61. RTI Surgical Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. MiMedx Group Corporate Information, Head Office, and Major Competitors
Table 63. MiMedx Group Major Business
Table 64. MiMedx Group Artificial Dermal Matrix Product and Solutions
Table 65. MiMedx Group Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Tides Medical Corporate Information, Head Office, and Major Competitors
Table 67. Tides Medical Major Business
Table 68. Tides Medical Artificial Dermal Matrix Product and Solutions
Table 69. Tides Medical Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Ventris Medical Corporate Information, Head Office, and Major Competitors
Table 71. Ventris Medical Major Business
Table 72. Ventris Medical Artificial Dermal Matrix Product and Solutions
Table 73. Ventris Medical Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Vivex Biomedical Corporate Information, Head Office, and Major Competitors
Table 75. Vivex Biomedical Major Business
Table 76. Vivex Biomedical Artificial Dermal Matrix Product and Solutions
Table 77. Vivex Biomedical Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Aedicell Corporate Information, Head Office, and Major Competitors
Table 79. Aedicell Major Business
Table 80. Aedicell Artificial Dermal Matrix Product and Solutions
Table 81. Aedicell Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Amniox Medical Corporate Information, Head Office, and Major Competitors
Table 83. Amniox Medical Major Business
Table 84. Amniox Medical Artificial Dermal Matrix Product and Solutions
Table 85. Amniox Medical Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. StimLabs Corporate Information, Head Office, and Major Competitors
Table 87. StimLabs Major Business
Table 88. StimLabs Artificial Dermal Matrix Product and Solutions
Table 89. StimLabs Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Skye Biologics Corporate Information, Head Office, and Major Competitors
Table 91. Skye Biologics Major Business
Table 92. Skye Biologics Artificial Dermal Matrix Product and Solutions
Table 93. Skye Biologics Artificial Dermal Matrix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 94. Global Artificial Dermal Matrix Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 95. Global Artificial Dermal Matrix Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 96. Breakdown of Artificial Dermal Matrix by Company Type (Tier 1, Tier 2 and Tier 3)
Table 97. Artificial Dermal Matrix Players Head Office, Products and Services Provided
Table 98. Artificial Dermal Matrix Mergers & Acquisitions in the Past Five Years
Table 99. Artificial Dermal Matrix New Entrants and Expansion Plans
Table 100. Global Artificial Dermal Matrix Revenue (USD Million) by Type (2017-2022)
Table 101. Global Artificial Dermal Matrix Revenue Share by Type (2017-2022)
Table 102. Global Artificial Dermal Matrix Revenue Forecast by Type (2023-2028)
Table 103. Global Artificial Dermal Matrix Revenue by Application (2017-2022)
Table 104. Global Artificial Dermal Matrix Revenue Forecast by Application (2023-2028)
Table 105. North America Artificial Dermal Matrix Revenue by Type (2017-2022) & (USD Million)
Table 106. North America Artificial Dermal Matrix Revenue by Type (2023-2028) & (USD Million)
Table 107. North America Artificial Dermal Matrix Revenue by Application (2017-2022) & (USD Million)
Table 108. North America Artificial Dermal Matrix Revenue by Application (2023-2028) & (USD Million)
Table 109. North America Artificial Dermal Matrix Revenue by Country (2017-2022) & (USD Million)
Table 110. North America Artificial Dermal Matrix Revenue by Country (2023-2028) & (USD Million)
Table 111. Europe Artificial Dermal Matrix Revenue by Type (2017-2022) & (USD Million)
Table 112. Europe Artificial Dermal Matrix Revenue by Type (2023-2028) & (USD Million)
Table 113. Europe Artificial Dermal Matrix Revenue by Application (2017-2022) & (USD Million)
Table 114. Europe Artificial Dermal Matrix Revenue by Application (2023-2028) & (USD Million)
Table 115. Europe Artificial Dermal Matrix Revenue by Country (2017-2022) & (USD Million)
Table 116. Europe Artificial Dermal Matrix Revenue by Country (2023-2028) & (USD Million)
Table 117. Asia-Pacific Artificial Dermal Matrix Revenue by Type (2017-2022) & (USD Million)
Table 118. Asia-Pacific Artificial Dermal Matrix Revenue by Type (2023-2028) & (USD Million)
Table 119. Asia-Pacific Artificial Dermal Matrix Revenue by Application (2017-2022) & (USD Million)
Table 120. Asia-Pacific Artificial Dermal Matrix Revenue by Application (2023-2028) & (USD Million)
Table 121. Asia-Pacific Artificial Dermal Matrix Revenue by Region (2017-2022) & (USD Million)
Table 122. Asia-Pacific Artificial Dermal Matrix Revenue by Region (2023-2028) & (USD Million)
Table 123. South America Artificial Dermal Matrix Revenue by Type (2017-2022) & (USD Million)
Table 124. South America Artificial Dermal Matrix Revenue by Type (2023-2028) & (USD Million)
Table 125. South America Artificial Dermal Matrix Revenue by Application (2017-2022) & (USD Million)
Table 126. South America Artificial Dermal Matrix Revenue by Application (2023-2028) & (USD Million)
Table 127. South America Artificial Dermal Matrix Revenue by Country (2017-2022) & (USD Million)
Table 128. South America Artificial Dermal Matrix Revenue by Country (2023-2028) & (USD Million)
Table 129. Middle East & Africa Artificial Dermal Matrix Revenue by Type (2017-2022) & (USD Million)
Table 130. Middle East & Africa Artificial Dermal Matrix Revenue by Type (2023-2028) & (USD Million)
Table 131. Middle East & Africa Artificial Dermal Matrix Revenue by Application (2017-2022) & (USD Million)
Table 132. Middle East & Africa Artificial Dermal Matrix Revenue by Application (2023-2028) & (USD Million)
Table 133. Middle East & Africa Artificial Dermal Matrix Revenue by Country (2017-2022) & (USD Million)
Table 134. Middle East & Africa Artificial Dermal Matrix Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Artificial Dermal Matrix Picture
Figure 2. Global Artificial Dermal Matrix Revenue Market Share by Type in 2021
Figure 3. From Animal Source
Figure 4. From Human Source
Figure 5. Artificial Dermal Matrix Revenue Market Share by Application in 2021
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Global Artificial Dermal Matrix Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 9. Global Artificial Dermal Matrix Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Artificial Dermal Matrix Revenue Market Share by Region (2017-2028)
Figure 11. Global Artificial Dermal Matrix Revenue Market Share by Region in 2021
Figure 12. North America Artificial Dermal Matrix Revenue (USD Million) and Growth Rate (2017-2028)
Figure 13. Europe Artificial Dermal Matrix Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Asia-Pacific Artificial Dermal Matrix Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. South America Artificial Dermal Matrix Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Middle East and Africa Artificial Dermal Matrix Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Artificial Dermal Matrix Market Drivers
Figure 18. Artificial Dermal Matrix Market Restraints
Figure 19. Artificial Dermal Matrix Market Trends
Figure 20. MTF Biologics Recent Developments and Future Plans
Figure 21. Allosource Recent Developments and Future Plans
Figure 22. Parametrics Medical Recent Developments and Future Plans
Figure 23. LifeNet Health Recent Developments and Future Plans
Figure 24. Gunze Recent Developments and Future Plans
Figure 25. Tissue Regenix Recent Developments and Future Plans
Figure 26. Zimmer Biomet Recent Developments and Future Plans
Figure 27. Integra LifeSciences Recent Developments and Future Plans
Figure 28. Organogenesis Recent Developments and Future Plans
Figure 29. Flower Orthopedics Recent Developments and Future Plans
Figure 30. Promethean Recent Developments and Future Plans
Figure 31. Wright Medical Group Recent Developments and Future Plans
Figure 32. Aziyo Biologics Recent Developments and Future Plans
Figure 33. RTI Surgical Recent Developments and Future Plans
Figure 34. MiMedx Group Recent Developments and Future Plans
Figure 35. Tides Medical Recent Developments and Future Plans
Figure 36. Ventris Medical Recent Developments and Future Plans
Figure 37. Vivex Biomedical Recent Developments and Future Plans
Figure 38. Aedicell Recent Developments and Future Plans
Figure 39. Amniox Medical Recent Developments and Future Plans
Figure 40. StimLabs Recent Developments and Future Plans
Figure 41. Skye Biologics Recent Developments and Future Plans
Figure 42. Global Artificial Dermal Matrix Revenue Share by Players in 2021
Figure 43. Artificial Dermal Matrix Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 44. Global Top 3 Players Artificial Dermal Matrix Revenue Market Share in 2021
Figure 45. Global Top 10 Players Artificial Dermal Matrix Revenue Market Share in 2021
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 47. Global Artificial Dermal Matrix Revenue Share by Type in 2021
Figure 48. Global Artificial Dermal Matrix Market Share Forecast by Type (2023-2028)
Figure 49. Global Artificial Dermal Matrix Revenue Share by Application in 2021
Figure 50. Global Artificial Dermal Matrix Market Share Forecast by Application (2023-2028)
Figure 51. North America Artificial Dermal Matrix Sales Market Share by Type (2017-2028)
Figure 52. North America Artificial Dermal Matrix Sales Market Share by Application (2017-2028)
Figure 53. North America Artificial Dermal Matrix Revenue Market Share by Country (2017-2028)
Figure 54. United States Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Canada Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Mexico Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Europe Artificial Dermal Matrix Sales Market Share by Type (2017-2028)
Figure 58. Europe Artificial Dermal Matrix Sales Market Share by Application (2017-2028)
Figure 59. Europe Artificial Dermal Matrix Revenue Market Share by Country (2017-2028)
Figure 60. Germany Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. France Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. United Kingdom Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Russia Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Italy Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Asia-Pacific Artificial Dermal Matrix Sales Market Share by Type (2017-2028)
Figure 66. Asia-Pacific Artificial Dermal Matrix Sales Market Share by Application (2017-2028)
Figure 67. Asia-Pacific Artificial Dermal Matrix Revenue Market Share by Region (2017-2028)
Figure 68. China Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Japan Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South Korea Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. India Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Southeast Asia Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Australia Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South America Artificial Dermal Matrix Sales Market Share by Type (2017-2028)
Figure 75. South America Artificial Dermal Matrix Sales Market Share by Application (2017-2028)
Figure 76. South America Artificial Dermal Matrix Revenue Market Share by Country (2017-2028)
Figure 77. Brazil Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Argentina Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Middle East and Africa Artificial Dermal Matrix Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Artificial Dermal Matrix Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Artificial Dermal Matrix Revenue Market Share by Country (2017-2028)
Figure 82. Turkey Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Saudi Arabia Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. UAE Artificial Dermal Matrix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

MTF Biologics
Allosource
Parametrics Medical
LifeNet Health
Gunze
Tissue Regenix
Zimmer Biomet
Integra LifeSciences
Organogenesis
Flower Orthopedics
Promethean
Wright Medical Group
Aziyo Biologics
RTI Surgical
MiMedx Group
Tides Medical
Ventris Medical
Vivex Biomedical
Aedicell
Amniox Medical
StimLabs
Skye Biologics
jiaGou

Add To Cart

gouMai

Buy Now